Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2019, Article ID 7593560, 8 pages
https://doi.org/10.1155/2019/7593560
Review Article

Prognostic Significance of the Lymphocyte-to-Monocyte Ratio in Bladder Cancer Undergoing Radical Cystectomy: A Meta-Analysis of 5638 Individuals

Department of Breast Surgery, Thyroid Surgery, Huangshi Central Hospital of Edong Healthcare Group, Hubei Polytechnic University, No. 141, Tianjin Road, Huangshi, Hubei, China

Correspondence should be addressed to Qin Liu; moc.621@qlyyxzsh

Received 15 November 2018; Revised 23 December 2018; Accepted 27 December 2018; Published 4 April 2019

Academic Editor: Massimiliano M. Corsi Romanelli

Copyright © 2019 Jian-ying Ma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Babjuk, M. Burger, E. Compérat et al., “Reply to Harry Herr’s letter to the editor re: Marko Babjuk, Andreas Bohle, Maximilian Burger, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 2017; 71: 447-61,” European urology, vol. 71, no. 6, pp. e173–e174, 2017. View at Publisher · View at Google Scholar · View at Scopus
  2. P. E. Clark, P. E. Spiess, N. Agarwal et al., “NCCN guidelines insights: bladder cancer, version 2.2016,” Journal of the National Comprehensive Cancer Network, vol. 14, no. 10, pp. 1213–1224, 2016. View at Publisher · View at Google Scholar
  3. M. B. Amin, S. C. Smith, V. E. Reuter et al., “Update for the practicing pathologist: the International Consultation On Urologic Disease-European Association of Urology consultation on bladder cancer,” Modern Pathology, vol. 28, no. 5, pp. 612–630, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Kang, C. W. Jeong, C. Kwak, H. H. Kim, and J. H. Ku, “Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor,” Oncotarget, vol. 8, no. 8, pp. 12891–12901, 2017. View at Publisher · View at Google Scholar · View at Scopus
  5. S. I. Grivennikov, F. R. Greten, and M. Karin, “Immunity, inflammation, and cancer,” Cell, vol. 140, no. 6, pp. 883–899, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. T. K. Oh and Y. R. Choi, “The high-sensitivity C-reactive protein/albumin ratio predicts long-term oncologic outcomes after curative resection for hepatocellular carcinoma,” Journal of Clinical Medicine, vol. 7, no. 6, 2018. View at Publisher · View at Google Scholar
  7. H. Fujikawa, Y. Toiyama, Y. Inoue et al., “Prognostic impact of preoperative albumin–to–globulin ratio in patients with colon cancer undergoing surgery with curative intent,” Anticancer Research, vol. 37, no. 3, pp. 1335–1342, 2017. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Gkika, D. Bettinger, L. Krafft et al., “The role of albumin–bilirubin grade and inflammation-based index in patients with hepatocellular carcinoma treated with stereotactic body radiotherapy,” Strahlentherapie und Onkologie, vol. 194, no. 5, pp. 403–413, 2018. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Hu and Q. Liu, “Prognostic significance of platelet-to-lymphocyte ratio in cholangiocarcinoma: a meta-analysis,” BioMed Research International, vol. 2018, Article ID 7375169, 8 pages, 2018. View at Publisher · View at Google Scholar
  10. Y. Mano, T. Yoshizumi, K. Yugawa et al., “Lymphocyte-to-monocyte ratio is a predictor of survival after liver transplantation for hepatocellular carcinoma,” Liver transplantation, vol. 24, no. 11, pp. 1603–1611, 2018. View at Publisher · View at Google Scholar
  11. K. Watanabe, A. Yasumoto, Y. Amano et al., “Mean platelet volume and lymphocyte-to-monocyte ratio are associated with shorter progression-free survival in EGFR-mutant lung adenocarcinoma treated by EGFR tyrosine kinase inhibitor,” PLoS One, vol. 13, no. 9, article e0203625, 2018. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Shimura, M. Shibata, K. Gonda et al., “Prognostic impact of preoperative lymphocyte-to-monocyte ratio in patients with colorectal cancer with special reference to myeloid-derived suppressor cells,” Fukushima Journal of Medical Science, vol. 64, no. 2, pp. 64–72, 2018. View at Publisher · View at Google Scholar
  13. M. Miyake, Y. Morizawa, S. Hori et al., “Integrative assessment of pretreatment inflammation-, nutrition-, and muscle-based prognostic markers in patients with muscle-invasive bladder cancer undergoing radical cystectomy,” Oncology, vol. 93, no. 4, pp. 259–269, 2017. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Lucca, S. L. Hofbauer, C. V. Leitner et al., “Development of a preoperative nomogram incorporating biomarkers of systemic inflammatory response to predict nonorgan-confined urothelial carcinoma of the bladder at radical cystectomy,” Urology, vol. 95, pp. 132–138, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. S. M. Lee, A. Russell, and G. Hellawell, “Predictive value of pretreatment inflammation-based prognostic scores (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio) for invasive bladder carcinoma,” Korean Journal of Urology, vol. 56, no. 11, pp. 749–755, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Stang, “Critical evaluation of the Newcastle-Ottawa Scale for the assessment of the quality of nonrandomized studies in meta-analyses,” European Journal of Epidemiology, vol. 25, no. 9, pp. 603–605, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. M. K. Parmar, V. Torri, and L. Stewart, “Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints,” Statistics in Medicine, vol. 17, no. 24, pp. 2815–2834, 1998. View at Publisher · View at Google Scholar
  18. J. F. Tierney, L. A. Stewart, D. Ghersi, S. Burdett, and M. R. Sydes, “Practical methods for incorporating summary time-to-event data into meta-analysis,” Trials, vol. 8, no. 1, p. 16, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Rajwa, M. Zyczkowski, A. Paradysz, K. Bujak, and P. Bryniarski, “Evaluation of the prognostic value of LMR, PLR, NLR, and dNLR in urothelial bladder cancer patients treated with radical cystectomy,” European Review for Medical and Pharmacological Sciences, vol. 22, no. 10, pp. 3027–3037, 2018. View at Publisher · View at Google Scholar
  20. D. D'Andrea, M. Moschini, K. M. Gust et al., “Lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio as biomarkers for predicting lymph node metastasis and survival in patients treated with radical cystectomy,” Journal of Surgical Oncology, vol. 115, no. 4, pp. 455–461, 2017. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Yoshida, H. Kinoshita, K. Yoshida et al., “A novel risk stratification model, involving preoperative lymphocyte-monocyte ratio and standard pathological factors, for overall survival in patients with bladder cancer undergoing radical cystectomy,” Japanese journal of clinical oncology, vol. 45, no. 12, pp. 1162–1167, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. G. M. Zhang, Y. Zhu, L. Luo et al., “Preoperative lymphocyte-monocyte and platelet-lymphocyte ratios as predictors of overall survival in patients with bladder cancer undergoing radical cystectomy,” Tumour Biology, vol. 36, no. 11, pp. 8537–8543, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Temraz, D. Mukherji, Z. A. A. Farhat et al., “Preoperative lymphocyte-to-monocyte ratio predicts clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: a retrospective analysis,” BMC Urology, vol. 14, no. 1, p. 76, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. X. Wang, A. Baihetiya, and X. D. Li, “Preoperative neutrophil-lymphocyte ratio and lymphocyte-monocyte ratio predict the prognosis of patients with non-muscle invasive bladder cancer,” Journal of Modern Urology, vol. 24, pp. 1–7, 2018. View at Google Scholar
  25. J. S. Palumbo and J. L. Degen, “Mechanisms coupling the hemostatic system to colitis-associated cancer,” Thrombosis research, vol. 125, Supplement 2, pp. S39–S43, 2010. View at Publisher · View at Google Scholar
  26. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill, “Cancer-related inflammation,” Nature, vol. 454, no. 7203, pp. 436–444, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Bastid, N. Bonnefoy, J. F. Eliaou, and A. Bensussan, “Lymphocyte-derived interleukin-17A adds another brick in the wall of inflammation-induced breast carcinogenesis,” Oncoimmunology, vol. 3, no. 4, article e28273, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. K. J. Chen, L. Zhou, H. Y. Xie, T. E. Ahmed, X. W. Feng, and S. S. Zheng, “Intratumoral regulatory T cells alone or in combination with cytotoxic T cells predict prognosis of hepatocellular carcinoma after resection,” Medical Oncology, vol. 29, no. 3, pp. 1817–1826, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Zhou, T. Ding, W. Pan, L. Y. Zhu, L. Li, and L. Zheng, “Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients,” International Journal of Cancer, vol. 125, no. 7, pp. 1640–1648, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. T. A. Zikos, A. D. Donnenberg, R. J. Landreneau, J. D. Luketich, and V. S. Donnenberg, “Lung T-cell subset composition at the time of surgical resection is a prognostic indicator in non-small cell lung cancer,” Cancer Immunology, Immunotherapy, vol. 60, no. 6, pp. 819–827, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Minami, T. Minami, N. Shimizu et al., “Identification of programmed death ligand 1-derived peptides capable of inducing cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma,” Journal of Immunotherapy, vol. 38, no. 7, pp. 285–291, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Chanmee, P. Ontong, K. Konno, and N. Itano, “Tumor-associated macrophages as major players in the tumor microenvironment,” Cancers, vol. 6, no. 3, pp. 1670–1690, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Yang, Z. Li, M. Ren et al., “Stromal infiltration of tumor-associated macrophages conferring poor prognosis of patients with basal-like breast carcinoma,” Journal of Cancer, vol. 9, no. 13, pp. 2308–2316, 2018. View at Publisher · View at Google Scholar · View at Scopus
  34. W. J. Zhang, X. H. Wang, S. T. Gao et al., “Tumor-associated macrophages correlate with phenomenon of epithelial-mesenchymal transition and contribute to poor prognosis in triple-negative breast cancer patients,” The Journal of surgical research., vol. 222, pp. 93–101, 2018. View at Publisher · View at Google Scholar · View at Scopus